Calif. Genetic Test Co. Pays $11M To Resolve FCA Claims
A Silicon Valley-based prenatal testing company has agreed to pay $10.6 million to resolve allegations that it improperly billed federal health care programs for its popular Panorama noninvasive prenatal tests and...To view the full article, register now.
Already a subscriber? Click here to view full article